Cancer scientists in Britain are launching what they call the world’s first Darwinian drug development program in a bid to get ahead of cancer’s ability to become resistant to even the newest treatments and recur in many patients.
from The Daily Star >> Live News http://bit.ly/2Vut17F
from The Daily Star >> Live News http://bit.ly/2Vut17F